“Dimethyl Itaconate As A Novel Anti-Inflammatory Agent Targeting Tnf-Α-Driven Nf-Κb Activation In Epithelial Cell Models”. The Review of Diabetic Studies (September 10, 2025): 1–21. Accessed March 27, 2026. https://www.diabeticstudies.org/index.php/RDS/article/view/493.